IA Global Ventures Invests in Imagenyx: The Surgery Is Only Half the Story

A vascular procedure can go exactly as planned and still end with a patient losing a limb.

That sounds contradictory. It isn’t.

The difficult part of treating patients at risk of limb loss does not always end when the procedure is over. After discharge, patients can move between hospitals, wound-care facilities, home-health providers and their own homes. Information does not always move with them. A wound can begin to deteriorate without the clinical team having a clear view of what is happening.

By the time someone sees the patient again, the window to intervene may already be closing.

This is the problem that led us to Imagenyx.

Imagenyx founders Lucas Ferrer, MD, and Dimitrios Miserlis, MD

The company was founded by Dimitrios Miserlis, MD, and Lucas Ferrer, MD, both practicing vascular surgeons. They did not discover this problem by studying a market report. They spent years seeing it in front of them.

That distinction matters.

The best healthcare companies are often built by people who have lived inside the workflow they are trying to change. They know where information gets lost, where decisions slow down and, most importantly, where a small delay can become a very different outcome for the patient. Imagenyx is building around that gap.

Its platform brings together information from the post-operative journey and uses AI to help predict how a wound is healing and identify patients whose condition may be deteriorating. It is designed to connect hospitals, wound-care facilities, home-health providers and patients, giving care teams greater visibility between clinical encounters.

The goal is to give physicians something they often lack after discharge: visibility early enough to act. That changes the question.

Instead of asking, “What happened to this patient?” after the wound has deteriorated, the system can begin asking, “Where is this patient heading?”

That is a much more valuable question.

Healthcare has no shortage of data. The harder problem is turning scattered information into a useful signal at the moment a decision needs to be made. This is also why Imagenyx fits the way we think about applied AI.

At IA Global Ventures, we believe some of the most important companies are created when deep expertise meets a problem that has been accepted for too long as simply “the way things work.” The post-operative gap is one of those problems.

The opportunity with Imagenyx is to make the right information arrive before it is too late. That is why we invested in Imagenyx.

And that is what makes the company worth watching.

 

Share